Depo Shot Lawsuit Settlement Amounts | Projections & Estimates

Projections & Estimates for Depo-Provera Shot Lawsuit Settlements

Settlement amounts for Depo-Provera Lawsuits vary based on the severity of health complications, the impact on the plaintiff’s life, and the level of negligence attributed to Pfizer, the drug’s manufacturer.

Attorneys estimate that potential settlements may range from $100,000 to $500,000 or more, depending on case-specific factors.

These factors include the extent of medical treatment required, long-term or permanent damage caused by brain tumors, and the emotional and financial toll on the affected individuals and their families.

Critical elements, such as establishing a clear connection between Depo-Provera use and the brain tumor, as well as demonstrating Pfizer’s failure to provide adequate warnings, will also influence compensation.

Cases involving severe health impacts and diminished daily functioning are likely to receive higher settlement amounts due to the profound life-altering consequences experienced by plaintiffs.

The settlement value of a Depo-Provera Lawsuit depends on individual factors, the trajectory of the litigation, and more.

Please be advised that any projected or estimated settlement amounts mentioned on this page are general estimations and are not guaranteed. These figures are based on similar previous litigations, the nature of injuries sustained, and estimated costs of damages. They are meant to provide a general idea of what settlement ranges could look like and should not be taken as definitive expectations for your case.

Every legal case is unique, with its own specific circumstances that can significantly affect the outcome. This information is not legal advice and does not address the specifics of your situation. To obtain a more accurate understanding of the potential value of your case, it is best to consult directly with a qualified attorney who can provide personalized guidance.

Tier One: $300,000 – $500,000+ (Severe Cases)

Tier One Depo-Provera cases typically involve catastrophic injuries tied to a confirmed brain or spinal tumor diagnosis, often requiring aggressive medical intervention and long-term monitoring.

These claims tend to fall at the top end of projected settlement ranges because they involve measurable, life-altering harm that directly affects daily functioning and future medical needs.

Many plaintiffs in this tier report documented tumor growth over time, along with serious neurological symptoms that interfere with work, mobility, or cognitive performance.

Because Depo-Provera is an injectable birth control shot administered repeatedly over months or years, attorneys often focus on cumulative exposure when evaluating medical causation and case value.

In active pharmaceutical litigation, these severe cases generally carry higher projected settlement potential due to the scale of damages, the cost of ongoing care, and the permanency of the injury.

• Confirmed diagnosis of a meningioma or other brain or spinal tumor
• Evidence of measurable tumor growth on imaging scans over time
• Surgical intervention, radiation treatment, or long-term neurological monitoring
• Permanent neurological impairment, chronic headaches, vision changes, or seizure activity
• Significant medical costs, lifelong care needs, and substantial lost wages are often involved.

• Plaintiffs requiring extensive brain surgery and experiencing permanent cognitive, motor, or sensory impairments may fall into this category.
• Cases may also include severe emotional and financial burdens on the patient and their family.

Tier Two: $200,000 – $300,000 (Moderate Cases)

Tier Two cases generally involve significant but less permanently disabling injuries associated with Depo-Provera meningioma lawsuit claims.

Plaintiffs in this category are often diagnosed with a meningioma that required medical treatment but did not result in profound, lasting neurological impairment.

Many used birth control injections for an extended period before symptoms such as persistent headaches, vision disturbances, or balance issues led to diagnostic imaging.

In these moderate cases, treatment may include surgery or ongoing monitoring without severe post-operative complications or permanent loss of function.

Individuals filing lawsuits in this tier typically present documented medical evidence, treatment records, and proof of damages that justify substantial but not top-tier settlement valuations.

• Confirmed meningioma diagnosis linked to prior birth control injections
• Surgical removal with recovery and limited long-term neurological deficit
• Ongoing medical monitoring without extensive permanent disability
• Documented lost wages during treatment and recovery
• Strong supporting medical records for Depo-Provera meningioma lawsuit claims

Tier Three: $100,000 – $200,000 (Mild to Moderate Cases)

Tier Three cases typically involve confirmed injuries that required medical evaluation and monitoring, but did not lead to major surgery, permanent disability, or extensive long-term impairment.

Plaintiffs in this category may have been diagnosed with a smaller or slower-growing tumor, or experienced symptoms that improved with treatment and careful observation.

While the physical impact may be less severe than higher tiers, these cases still reflect serious health risks tied to a condition that can worsen over time. Many claims in this range focus on the financial burden of diagnostic imaging, specialist appointments, and ongoing follow-up care.

In broader dangerous drugs litigation, Tier Three cases still carry meaningful settlement value because the diagnosis alone can disrupt a person’s life, employment, and long-term medical outlook.

• Confirmed diagnosis with symptoms that required medical evaluation and follow-up
• Ongoing imaging scans and neurological monitoring without invasive treatment
• Mild to moderate functional impairment, often managed through treatment or observation
• Medical expenses tied to diagnosis, specialist care, and continued surveillance
• Documented emotional distress tied to the long-term uncertainty of the condition and its serious health risks

What is the New Depo-Provera Lawsuit?

The active lawsuit Depo Provera is named in concerns the increased risk of developing meningioma brain tumors linked to the prolonged use of Depo Provera.

Plaintiffs allege that Pfizer, the drug’s manufacturer, failed to provide adequate warnings about the risk of developing these tumors, leaving patients and healthcare providers unaware of the potential dangers associated with long-term use.

Recent studies have prompted legal action from individuals who developed these brain tumors, with many claiming significant harm due to Pfizer’s negligence.

The lawsuits further assert that Pfizer had access to clinical data and medical research that indicated an elevated risk but chose not to update the drug’s U.S. label to reflect this information.

Plaintiffs are seeking compensation for medical expenses, lost wages, pain and suffering, and other damages related to their diagnoses.

The Depo-Provera Lawsuit has been officially consolidated into multidistrict litigation (MDL), which allows for centralized pretrial proceedings while preserving each plaintiff’s individual claims.

Attorneys representing the plaintiffs emphasize the life-altering consequences of these brain tumors, which often require invasive treatments and carry long-term health risks.

In some cases, plaintiffs have experienced permanent neurological impairments that affect their ability to work or enjoy daily life.

The Depo-Provera Lawsuit aims to hold Pfizer accountable for its alleged failure to disclose the full extent of Depo-Provera’s risks and to provide justice for those harmed.

If successful, these cases could lead to significant settlements or judgments that reflect the gravity of the harm caused.

If you or a loved one used the contraceptive drug Depo-Provera and subsequently developed a brain tumor, you may be eligible to file a Depo Provera Lawsuit.

Contact the Depo-Provera Attorneys at TorHoerman Law for a free consultation.

Use the chat feature on this page to find out if you’re eligible to file a Depo-Provera Lawsuit instantly.

Is There a Depo-Provera Class Action Lawsuit?

No, there is not a Depo Provera Class Action Lawsuit.

However, Depo Provera claims are being consolidated into multidistrict litigation (MDL).

MDL is a separate and distinct legal process from class action lawsuits.

The Depo Provera MDL consolidates all Depo Provera cases into a single federal court, streamlining the legal process and allowing for those who’ve developed brain tumors linked to Depo Provera use to seek individualized compensation in an organized manner.

Unlike a class action, where all plaintiffs are treated as a single group and receive the same outcome, an MDL allows each case to remain separate while sharing common pretrial proceedings.

This structure ensures that individual circumstances, such as the severity of injuries and the specific impact on a plaintiff’s life, are considered when determining compensation.

While MDL centralizes evidence gathering and judicial oversight to improve efficiency, it does not result in a collective settlement or verdict like a class action.

Plaintiffs in an MDL retain their right to pursue unique claims and negotiate individual settlements based on their specific damages.

Gathering Evidence for a Depo Shot Lawsuit

Gathering strong evidence is a crucial step in building a compelling Depo-Provera Lawsuit.

This evidence helps establish the link between Depo-Provera use and the development of brain tumors, demonstrating the extent of harm caused by the drug.

A well-documented case can significantly improve your chances of achieving fair compensation for your medical expenses, lost wages, and other damages.

Your attorney can help you gather evidence relating to brain tumors, Depo Provera usage, subsequent impacts on your life, and more.

Evidence That May Be Used in a Depo-Provera Lawsuit:

• Medical Records: Diagnosis reports, imaging scans, and treatment plans for brain tumors.
• Prescription History: Proof of Depo-Provera use, including dates, dosages, and refill information.
• Doctor’s Notes and Expert Testimony: Statements linking the brain tumor to Depo-Provera usage.
• Product Labels and Patient Leaflets: Documentation showing inadequate warnings about the risks.
• Financial Records: Evidence of lost wages, medical expenses, and other economic losses.
• Personal Health Logs and Medical History: Detailed accounts of symptoms and their progression over time.

Potential Damages in a Depo Shot Lawsuit

Understanding potential damages is essential for those considering a Depo-Provera Lawsuit.

Damages in a lawsuit refer to the compensation sought to address the physical, emotional, and financial losses caused by the drug.

A qualified attorney can help assess the full scope of your damages and pursue fair compensation for the harm you’ve endured.

Potential Damages in a Depo-Provera Lawsuit:

• Medical Expenses: Medical bills related to surgeries, treatments, hospital stays, and ongoing care.
• Lost Wages: Compensation for income lost during treatment and recovery, as well as diminished earning capacity.
• Pain and Suffering: Damages for physical pain and emotional distress caused by the illness and its effects.
• Emotional Distress: Compensation for anxiety, depression, or trauma resulting from the diagnosis and treatment.
• Loss of Quality of Life: Compensation for reduced ability to engage in daily activities and enjoy life.
• Future Medical Costs: Projected expenses for long-term care, rehabilitation, or monitoring.
• Permanent Disability: Compensation for lasting impairments or disabilities resulting from the condition.

Long Term Depo-Provera Usage Linked to Increased Risk of Brain Tumors

Recent research has identified a significant association between taking Depo-Provera, a contraceptive injection containing medroxyprogesterone acetate, and an increased risk of developing intracranial meningiomas—tumors arising from the brain’s protective membranes.

A French national case-control study published in the British Medical Journal in March 2024 analyzed over 18,000 cases of women who underwent surgery for meningioma between 2009 and 2018.

The study found that women who used medroxyprogesterone acetate injections for more than one year had a 5.6-fold increased risk of developing these tumors compared to non-users.

Meningiomas are typically benign but can lead to serious health issues due to their location and potential to compress adjacent brain structures, resulting in symptoms like severe headaches, vision problems, and seizures.

The study also examined other progestogens, such as medrogestone and promegestone, and found that prolonged use was associated with a 4.1-fold and 2.7-fold increased risk of meningioma, respectively.

Depo-Provera claims allege that Pfizer knew about the potential link between the contraceptive injection and the increased risk of brain tumors, but failed to warn patients and healthcare providers.

Despite these findings, plaintiffs claim that Pfizer did not update the U.S. product labels to reflect this risk, even though similar warnings were added in other countries.

Depo-Provera’s label was updated to include the risk of brain tumors in the UK and European Union.

In December 2025, Depo-Provera’s label was updated in the United States to reflect the brain tumor risk.

Depo-Provera Label Update (December 2025)

In December 2025, the labeling for Depo-Provera was updated to reflect growing concerns about the potential neurological risks associated with long-term use of the birth control drug.

This update drew attention because it signaled a shift in how the manufacturer and regulators framed the safety profile of the medication, particularly regarding intracranial tumors such as meningiomas.

The revised warning language has become a central point of discussion in ongoing litigation, especially for plaintiffs alleging they were never properly informed of the risk before receiving repeated injections.

The update is also significant because it applies specifically to Depo-Provera CI, the contraceptive injection formulation used widely in the United States.

For many plaintiffs, the December 2025 label change is being treated as an acknowledgment that risk information should have been more clearly communicated earlier, particularly to patients receiving the drug for extended periods.

In Depo-Provera birth control lawsuits, this labeling revision is frequently referenced as part of the broader argument that users lacked adequate warning about potential tumor-related complications.

TorHoerman Law: Accepting New Clients for the Depo-Provera Lawsuit

Hormonal contraceptives like Depo-Provera should be safe and effective, but when reports arise about potential serious side effects like brain tumors, legal investigation is absolutely necessary.

Scientific studies linking the contraceptive to an increased risk of intracranial meningiomas have raised significant concerns about the safety of prolonged use.

These tumors, while often benign, can have devastating effects on a person’s health, requiring invasive treatments and causing long-term complications.

Women who were not adequately warned about these risks deserve accountability and the opportunity to seek justice for the harm caused.

Our Depo-Provera Lawyers are investigating claims from women who have developed brain tumors after long term Depo-Provera use.

If you or a loved one developed brain tumors after using Depo-Provera, you may be eligible to file a claim.

Contact our legal team today for a free consultation and personalized guidance.

Use the chat feature on this page for a free case evaluation to find out if you qualify to file a Depo-Provera Lawsuit instantly.